Delivery Order SPE2DB24D2013-SPE2DB25FCJKR

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in units of 30, with a ceiling value of $1,127.92. The contract is a firm fixed-price delivery order with a performance period extending through June 16, 2025. This order is not set-aside and was competitively awarded. Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,815.04, is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract has a period of performance through December 6, 2024 and is a firm fixed-price delivery order contract. No set-aside designation is noted. AmerisourceBergen is the prime contractor...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit-dose packages of 30, with a ceiling value of $5,020.25. The contract is a firm fixed-price delivery order with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract is a firm fixed-price delivery order with a ceiling value of $5,608.56 and a period of performance through January 27, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,553.64, is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units. The contract is a firm fixed-price delivery order, with a period of performance through May 8, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,851.03, is for the provision of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count unit doses. The award was made on January 7, 2025, with an ultimate completion date of January 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that...
This is a $4,330.99 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in units of 30. The contract has a firm fixed price of $31,306.84 and a completion date of September 12, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-25 mg tablets, a medication used to treat hypertension. The contract is a firm fixed-price delivery order with a ceiling value of $10,006.35 and a period of performance through July 15, 2024. The contract was not set aside for any specific business...
This is a $1,956.76 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in 30-count units. The contract has an ultimate completion date of June 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. The company holds a significant $999,999,999.00 Indefinite Delivery...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB25FCJKR
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packages of 30, with a ceiling value of $3,200.95 and a period of performance through June 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM) and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract supports the federal government's medical supply requirements, particularly for military and veteran healthcare systems.

Generated 9/16/25, 10:03 AM